Latest Information Update: 19 May 2004
At a glance
- Originator Roche
- Mechanism of Action G protein-coupled receptor antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Overactive bladder
Most Recent Events
- 30 Apr 2004 Discontinued - Preclinical for Overactive bladder in USA (unspecified route)
- 17 Mar 2003 Preclinical trials in Overactive bladder in USA (unspecified route)